New roles in pharmacy - learning from the All Wales Common Ailments Scheme by Mantzourani, Efthymia et al.
New roles in pharmacy – learning from the All Wales
Common Ailments Scheme
Efi Mantzourani, Thomas Gwyn Richards and Mary Louise Hughes
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales
Keywords
common ailments service; community
pharmacy; expanding role; new services;
service evaluation
Correspondence
Dr Efthymia Mantzourani, Cardiff School of
Pharmacy and Pharmaceutical Sciences,
Redwood Building, King Edward VII Avenue,
Cardiff CF10 3NB, Wales.
E-mail: MantzouraniE1@cardiff.ac.uk
Received October 14, 2014
Accepted September 14, 2015
doi: 10.1111/ijpp.12231
All authors had access to the original data
(transcripts)
Abstract
Objectives The objective of this study was to explore the perceptions of stakehold-
ers on a national pilot of a new service, the ‘Choose Pharmacy’ Common Ailments
Service (CAS) in Wales
Methods Methods used were semi-structured interviews with stakeholders
involved in development and delivery of the CAS. Snowball sampling was employed
and invites were extended to eight of 13 pharmacies offering CAS in Cwm Taf LHB,
the practice managers at two associated general practitioner surgeries and two local
and national level commissioners.
Key findings The benefits of encouraging self-care by patients were widely recog-
nised in terms of their impact on patients, health professionals and wider society.
Although some challenges of introducing a new service were identified, these did not
appear to be insurmountable.
Conclusions CAS was welcomed by stakeholders in terms of its potential benefits.
Results are therefore encouraging for policy makers involved in the implementation
of other new roles within community pharmacy in the UK and beyond.
Introduction
Minor or common ailments are defined as acute health com-
plaints, which are self-limiting or can be treated straightfor-
wardly by patients themselves with minimal medical
intervention.[1] In October 2013, the Welsh Government
announced the national ‘Choose Pharmacy’ Common
Ailment Scheme (CAS), with the aim of making ‘community
pharmacy the first port of call for the provision of advice and
where necessary treatment of common illnesses’.[2] While the
benefits of CASs have previously been identified in quantita-
tive terms, few studies have investigated the perspective of
those involved in their development and delivery.[3,4] The aim
of this study was to explore the perceptions of stakeholders
involved in all stages of the pilot of the All Wales CAS.
Methods
This study was designed through an interpretivist para-
digm.[5] It was based in the Cwm Taf University Health Board
area. Eight out of 13 pharmacies offering CAS were invited to
participate; this represents a cohort of 25% of the pharmacies
piloting the service in Wales. Other stakeholders identified
were general practitioner (GP) practice managers working at
a local surgery, involved in patient referral, and two key
informants i.e. one individual from the local Health Board
and one from the Welsh Government involved in developing
and commissioning the service. Staff with limited involve-
ment in the scheme (locums and healthcare assistants) were
not included in the sampling frame. Purposive and snowball
sampling methods were employed.
Approval was received from Cardiff School of Pharmacy
and Pharmaceutical Sciences Research Ethics Committee.
Signed informed consent was obtained prior to data
collection.
Semi-structured interviews were conducted by an inde-
pendent researcher, based on a core interview schedule
(Appendix 1), with specific prompts for each stakeholder
group. The interviews were audio-recorded and transcribed
ad verbatim. The anonymised transcriptions were themati-
cally analysed inductively, using constant comparison to
reveal overarching themes.
Results
Eleven stakeholders: seven pharmacists, two GP practice
managers and two key informants agreed to participate and
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were interviewed between February and March 2014. Three
themes emerged related to perceptions and attitudes towards
the scheme (Table 1).
Pharmacist professional image
All stakeholders noted that with the advent of clinical phar-
macy services within community pharmacy, patients are
accepting of the pharmacy setting for consultations and
receiving treatment. However, it was felt there was still a lack
of understanding of the role of the modern-day pharmacist.
For the pharmacist stakeholders, additionally CAS was an
ideal opportunity to improve the profession’s image and to
increase public and GP awareness of the services that phar-
macy can offer.
Promotion of self-care
The majority of the stakeholders’ expectations centred on
promoting patients’ use of pharmacies as the first port of call
for minor ailments, ultimately promoting self-care. Stake-
holders from all groups identified CAS as a valuable tool to
re-educate patients and increase their confidence in diagnos-
ing and treating minor ailments themselves, decreasing pres-
sures on GPs. The potential facilitation of patients with more
pressing health issues to consult their GP earlier was empha-
sised. Both key informants noted increased self-care could
reduce health expenditure and more prudent use of NHS
resources. However, there were concerns that low [self-care]
rather than high [GP appointments] users of NHS resources
would use the scheme, thus counteracting its rationale
(Table 1).
Challenges of introducing a new role
Pharmacists highlighted that even though CAS adds to work-
load, they recognise it as an important opportunity to
promote pharmacy.
Although all pharmacists felt prepared to offer CAS, they
perceived that GP receptionists, who make the vast majority
of suggestions to patients about entering the scheme, needed
more support and training for this role.
Pharmacists and practice managers reported either
unchanged or improved interdisciplinary relationships with
other stakeholders. Several interviewees recognised that
meeting other stakeholders during the development phase
increased understanding of each other’s roles and this early
engagement increased the sense of ownership. It was antici-
pated that relationships would continue to develop.
Discussion
Stakeholders viewed CAS as an opportunity to redefine the
community pharmacists’ image and promote their profes-
sional identity. Time and associated workload was considered
a barrier; however, this was tempered by a sense that per-
ceived benefits outweighed barriers. Pharmacists in the
present study felt they were sufficiently trained, as found else-
where,[6,7] but believed that further training may be required
for surgery staff.
Almost all interviewees associated the scheme with pro-
moting patients’ use of pharmacies as the first port of call for
advice and treatment of minor ailments, consistently using
the term ‘self-care’. This contrasts with the finding of an
earlier CAS evaluation in England, in which pharmacists did
not associate CAS with encouraging self-care,[6] despite this
concept being a high priority item in the UK Government’s
agenda at that time.[8]
This is an important finding as it perhaps signifies a shift in
pharmacists’ attitudes towards fostering a culture of self-care.
Strengths and limitations
This is the first qualitative review of the All Wales Common
Ailments Scheme national pilot. The findings are potentially
of interest to many countries, especially those who are
looking to enhance self-care as a means to promote prudent
healthcare. While it is acknowledged that the sample size was
small, a range of views and perspectives were uncovered,
helped by the inclusion of the majority of participating phar-
macists in the pilot region as well as the key informants from
the Health Board and Welsh Government. Although due to
the limited scale of the study, the results cannot be generalised
and it cannot be concluded that stakeholders’ perceptions
regarding CAS reached a point of theoretical saturation, the
last interviews unearthed no new concepts. Views of patient
and GPs will need to be sought for a more holistic review of
the scheme.
Conclusions
This study explored the pilot All Wales Common Ailments
Scheme from the perspectives of those involved in its design
and delivery. The service was welcomed by the stakeholders in
terms of its potential benefits, namely an improved public
image of community pharmacy and a societal shift towards
self-care for minor ailments. Although some challenges of
introducing a new service were identified, these did not
appear to be insurmountable. It was highlighted that engage-
ment in the early stages of the scheme increased sense of own-
ership among stakeholders. The service commissioners from
the Welsh Government and Local Health Boards must con-
tinue to engage with all CAS stakeholders to facilitate the
ongoing success of the scheme. Lessons learned from the
present study can help policy makers intending to develop
and introduce new community pharmacy services, whether
in the UK or beyond.
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Table 1 Themes related to perceptions and attitudes towards the CAS scheme, and illustrative quotes
Theme Example quote Participant
Pharmacist professional image As pharmacists we get to increase the profile and awareness of what pharmacists can offer.
We can offer a whole range of different services and have the clinical skills in place and
the facilities in place to offer these services. However, patients often don’t come to us
because they’re not really aware of the underpinning knowledge. Unfortunately a lot of
people still see us as tablet dispensers.
Pharmacist 1
I think the advice that they get with the consultation, because they’re speaking one-to-one
with the pharmacist, I think they benefit from advanced advice compared to what they
might get from a counter assistant.
Pharmacist 3
As the service grows and develops and an awareness of it grows, then hopefully people will
be using pharmacies as the first port of call.
Pharmacist 1
Promotion of self-care I want it to demonstrate we can successfully move patients from GP appointments into
community pharmacy for the pharmacist to treat them and ultimately I want them to be
able to move from that into self-care.
Key Informant 1
If the only thing you know about treating an illness is to go and see a GP, then you get a
prescription and it reinforces your belief that what you should always do is go back and
see a GP . . . [CAS] encourages patients to recognise their symptoms and be able to treat
themselves in the future without having to call on the NHS.
Key Informant 2
The main thing I think is to re-educate patients that they don’t need to use the service; they
could just come in and buy something for a minor ailment . . . self-care basically.
Pharmacist 4
We are drowning in primary care with non-essential things, people who feel that they are
unwell rather than are actually unwell.’
Practice Manager 1
If there were six patients going over there [pharmacy], then that’s an hour’s worth of
consultations from here [surgery] and that would greatly help and reduce our workload.
Practice Manager 2
[CAS] allows them to see the patients whose blood pressure isn’t controlled, allowing them
to see that patient earlier than they would have. If you do that enough times you prevent
strokes.
Key Informant 2
The greater benefit for Welsh Government is this one about promoting patients who are
able to self-care . . . treat themselves earlier, end up not progressing to a point where
they are very ill and therefore needing more interventionist or more urgent services that
are inevitably more expensive.
Key Informant 2
What, I don’t think we want to do, is push people who will readily buy medication for
conjunctivitis and other common ailments into the common ailments system. If patients
want to buy them, why should they be treated under the NHS when they don’t need to
be?
Pharmacist 2
Challenges of introducing a
new role
As well as trying to do all the other things they’re [pharmacists] trying to do, the
dispensing, the DMRs, the MURs and all the other services, they’d have fifty people
sitting in the pharmacy wanting minor ailments consultations, so they were really
nervous about us doing a big push on launch.
Key Informant 1
I think, yes it is time consuming, but to actually push pharmacy forward we need to be
giving this time to the service . . . I think it’s worthwhile time . . . in terms of the time you
put in for the image of the profession, I think it’s important.
Pharmacist 3
Hopefully it will improve relationships with GPs as well, so we’ll improve communication
and improve cross-sector working and again we’ll improve on things for the future.
Key Informant 1
When all the GPs emergency slots were filled, they [receptionists] were then being referred
regardless to CAS. Obviously under that system you are going to get an awful lot of
inappropriate referrals.
Pharmacist 1
It’s easier for them [receptionists] to make an appointment for somebody, they can do that
in seconds, than have to explain the scheme.
Practice Manager 2
Hopefully it will improve relationships with GPs as well, so we’ll improve communication
and improve cross-sector working and again we’ll improve on things for the future.
Key Informant 1
CAS, ‘Choose Pharmacy’ Common Ailments Service; DMR, Discharge Medicines Review; GP, general practitioner; MUR, Medicines Use Review;
NHS, National Health Service.
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Appendix
Pharmacist
Practice Manager
(if different to pharmacist) Key Informant (if different to pharmacist)
How long have you been involved in the scheme? Could you tell me a little bit about your role in the CAS?
Could you share your expectations of the CAS?
What do you perceive to be the benefits of the CAS for the stakeholders
involved?
• Pharmacist
• Patient
• GP
What do you perceive to be the benefits of the CAS for
the stakeholders involved?
• Pharmacist
• Patient
• GP
• LHBs
Could you tell me about any barriers you have encountered to the effective
implementation of the CAS?
The Welsh Assembly Government states that the aim of the CAS is to ‘make
community pharmacy the first port of call for the provision of advice and if
necessary treatment of common illnesses.’
How far do you feel the CAS has gone into achieving this aim?
How prepared do you feel to discuss the CAS with patients? Could you comment on why you think pharmacists
have been selected as a first port of call?
How has the CAS affected your working relationships with the local GPs?
There are two main methods of entry onto the CAS, either the patient can
self-refer themselves, or they can be referred by their GP surgery. Can you
tell me your views on these?
Could you talk me through how
you refer patients to the CAS?
Do you have any suggestions on how to improve the CAS?
Overall, how would you sum up your personal opinion of the scheme in a few
sentences?
Finally, is there anything you would like to add about the service I have not
covered?
Prompts and probes:
Can you tell me a little bit more about that?
Why is that?
Would you be able to comment more on?
Do you think there is any reason for that?
Could you explain what you mean?
What is your opinion on this?
Could you give me an example?
4 Learning from all Wales Common Ailments Scheme
© 2015 Royal Pharmaceutical Society International Journal of Pharmacy Practice 2015, ••, pp. ••–••
